UCB (UCBJF) Stock Price, Quote, News & History

UCB SA (UCBJF) Stock Price, Quote, News & History

UCBJFOTCPK

Trade with Public

$278.11

-33.73-10.82%

At close: Mar 6, 4:00 PM EST

Key Statistics

Open

$299.45

$278.11

Volume / Avg.

24.00 / 783.00

Day Range

$278.11 - $299.45

52 Wk Range

150.70 - 345.39

Market Cap

$52.84B

P/E Ratio

33.38

Dividend Yield

0.55%

Exchange

OTC

RSI

Short Interest

Days to Cover

512.29

Recent Ucb SA News

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.

Vandana Singh

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

Vandana Singh

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline

Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.58B

Investing Cash Flow (TTM)

286.00M

Financing Cash Flow (TTM)

-691.00M

Free Cash Flow (TTM)

1.19B

Capital Expenditure (TTM)

-391.00M

Net Change in Cash (TTM)

1.17B

Valuation Metrics

Enterprise Value

$57.60B

PE Ratio (TTM)

33.38

PE Ratio (FWD)

25.91

PEG Ratio (TTM)

2.07

PS Ratio (TTM)

6.72

PB Ratio (TTM)

4.70

Earnings Yield % (TTM)

3.00%

Earnings Yield % (FWD)

3.86%

EV / EBITDA (TTM)

18.97

Price / EBITDA (TTM)

20.20

Price / Free Cash Flow (TTM)

28.26

Book Value / Share

$66.41

Company Debt

Total Debt

$2.68B

LT Debt

$2.69B

LT Debt Issuance (TTM)

$77.00M

LT Debt Repayment (TTM)

-$215.00M

Total Cash

$1.61B

Debt to Equity

0.30

Issuance of Debt (TTM)

-$138.00M

Repayment of Debt (TTM)

-$215.00M

Key Statistics

Open

$299.45

$278.11

Volume / Avg.

24.00 / 783.00

Day Range

$278.11 - $299.45

52 Wk Range

150.70 - 345.39

Market Cap

$52.84B

P/E Ratio

33.38

Dividend Yield

0.55%

Exchange

OTC

RSI

Short Interest

Days to Cover

512.29

About

Sector

Health Care

Industry

Pharmaceuticals

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which h...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy UCB (UCBJF) stock?

You can purchase shares of UCB (OTCPK:UCBJF) through any online brokerage.

View our list of the best stock brokerages

Who are UCB (UCBJF) competitors?

There are no as such competitors for UCB.

What is the forecast, or price target, for UCB (UCBJF) stock?

There is no analysis for UCB to provide a consensus price target.

What is the current price for UCB (UCBJF)?

The stock price for UCB (OTCPK: UCBJF) is $278.11 last updated March 6, 2026 at 3:56 PM EST.

Does UCB (UCBJF) pay a dividend?

There are no upcoming dividends for UCB.

When is UCB (OTCPK:UCBJF) reporting earnings?

UCB does not have any upcoming earnings scheduled.

Is UCB (UCBJF) going to split?

There is no upcoming split for UCB.

What sector and industry does UCB (UCBJF) operate in?

UCB is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.

Key Statistics

Open

$299.45

$278.11

Volume / Avg.

24.00 / 783.00

Day Range

$278.11 - $299.45

52 Wk Range

150.70 - 345.39

Market Cap

$52.84B

P/E Ratio

33.38

Dividend Yield

0.55%

Exchange

OTC

RSI

Short Interest

Days to Cover

512.29

Recent Ucb SA News

Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle

CMS selects 15 high-cost prescription drugs for Medicare drug price negotiation program, expanding to include Part B drugs.

Vandana Singh

Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

Vandana Singh

J&J Halts Alzheimer's Trial After Drug Fails To Slow Clinical Decline

Johnson & Johnson ends its Phase 2b posdinemab trial after missing key Alzheimer's goals, raising concerns for next-generation tau-targeting drug programs.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

1.58B

Investing Cash Flow (TTM)

286.00M

Financing Cash Flow (TTM)

-691.00M

Free Cash Flow (TTM)

1.19B

Capital Expenditure (TTM)

-391.00M

Net Change in Cash (TTM)

1.17B

Valuation Metrics

Enterprise Value

$57.60B

PE Ratio (TTM)

33.38

PE Ratio (FWD)

25.91

PEG Ratio (TTM)

2.07

PS Ratio (TTM)

6.72

PB Ratio (TTM)

4.70

Earnings Yield % (TTM)

3.00%

Earnings Yield % (FWD)

3.86%

EV / EBITDA (TTM)

18.97

Price / EBITDA (TTM)

20.20

Price / Free Cash Flow (TTM)

28.26

Book Value / Share

$66.41

Company Debt

Total Debt

$2.68B

LT Debt

$2.69B

LT Debt Issuance (TTM)

$77.00M

LT Debt Repayment (TTM)

-$215.00M

Total Cash

$1.61B

Debt to Equity

0.30

Issuance of Debt (TTM)

-$138.00M

Repayment of Debt (TTM)

-$215.00M

Key Statistics

Open

$299.45

$278.11

Volume / Avg.

24.00 / 783.00

Day Range

$278.11 - $299.45

52 Wk Range

150.70 - 345.39

Market Cap

$52.84B

P/E Ratio

33.38

Dividend Yield

0.55%

Exchange

OTC

RSI

Short Interest

Days to Cover

512.29

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy UCB (UCBJF) stock?

You can purchase shares of UCB (OTCPK:UCBJF) through any online brokerage.

View our list of the best stock brokerages

Who are UCB (UCBJF) competitors?

There are no as such competitors for UCB.

What is the forecast, or price target, for UCB (UCBJF) stock?

There is no analysis for UCB to provide a consensus price target.

What is the current price for UCB (UCBJF)?

The stock price for UCB (OTCPK: UCBJF) is $278.11 last updated March 6, 2026 at 3:56 PM EST.

Does UCB (UCBJF) pay a dividend?

There are no upcoming dividends for UCB.

When is UCB (OTCPK:UCBJF) reporting earnings?

UCB does not have any upcoming earnings scheduled.

Is UCB (UCBJF) going to split?

There is no upcoming split for UCB.

What sector and industry does UCB (UCBJF) operate in?

UCB is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.